Sign in

CIK 0001719714 · Non-accelerated filer<br>Smaller reporting company

Mereo BioPharma Group plc

Sign in to watch
Ticker
MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
4403330237300
Business address
ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 8-K Event Regulation FD disclosure · Other events
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 8-K Event Results of operations
  6. 10-Q Report Quarterly Report
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 8-K Event Other events
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 8-K Event Shareholder vote results
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. ARS Other Annual Report to Security Holders
  20. DEF 14A Proxy Proxy Statement

Page 3 of 23 · 441 filings